POSB361 Quality of Life in Advanced Melanoma Patients in the Era of Novel Immuno- and Targeted Therapies

Autor: Franken, M, Leeneman, B, Aarts, M.J.B., van den Berkmortel, FWPJ, Blank, CU, Boers-Sonderen, MJ, van den Eertwegh, AJM, de Groot, JWB, Haanen, JBAG, Hospers, GAP, Kapiteijn, E, van Not, OJ, Piersma, D, van Rijn, RS, Stevense-den Boer, MAM, Suijkerbuijk, KPM, van der Veldt, AAM, Vreugdenhil, G, Wouters, MWJM, van Dongen, A, Uyl-De Groot, CA

Publikováno v: In Value in Health January 2022 25(1) Supplement:S230-S231

The introduction of mammographical screening has had little effect on the trend in breast-conserving surgery: a population-based study in Southeast Netherlands

Autor: Ernst, MF, Voogd, AC, Coebergh, Jan Willem, Repelaer van Driel, OJ, Roukema, JA

Publikováno v: European Journal of Cancer, 37, 2435-2440. Elsevier Ltd.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::4ac37c57ffc5c0d07edb4d2ca763652d
https://pure.eur.nl/en/publications/477e6373-81bc-4208-8822-ad5a555d4aae

Betekenis van steroidreceptoren voor de prognose en de hormonale behandeling van patiënten met mammacarcinoom : een retrospectieve studie in Zuid-oost Nederland

Autor: Voogd, AC, Crommelin, MA, Repelaer van Driel, OJ, Tutein Nolthenius-Puylaert, MC, Vreugdenhil, G, Coebergh, Jan Willem

Publikováno v: Nederlands Tijdschrift voor Geneeskunde, 142(31), 1772-1778. Bohn Stafleu van Loghum

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::5497a772dc5ca2a382fe24907e7378af
https://pure.eur.nl/en/publications/b6c6cdbf-36a1-46c1-9f51-9af31058eb63

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Long-Term Survival in Patients With Advanced Melanoma.

Autor: van Not OJ; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, the Netherlands.; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., van den Eertwegh AJM; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., Jalving H; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Bloem M; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, the Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Haanen JB; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., van Rijn RS; Department of Internal Medicine, Medical Center Leeuwarden, Leeuwarden, the Netherlands., Aarts MJB; Department of Medical Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, the Netherlands., van den Berkmortel FWPJ; Department of Medical Oncology, Zuyderland Medical Center Sittard, Sittard-Geleen, the Netherlands., Blank CU; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., de Groot J W B JW; Isala Oncology Center, Isala, Zwolle, the Netherlands., Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Leeneman B; Department of Health Technology Assessment, Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, the Netherlands.; Erasmus Center for Health Economics Rotterdam, Erasmus University Rotterdam, Rotterdam, the Netherlands., D P; Department of Internal Medicine, Medisch Spectrum Twente, Enschede, the Netherlands., Stevense-den Boer M; Department of Internal Medicine, Amphia Hospital, Breda, the Netherlands., van der Veldt AAM; Department of Medical Oncology and Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, the Netherlands., Vreugdenhil G G; Department of Internal Medicine, Maxima Medical Center, Eindhoven, the Netherlands., Wouters MWJM; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, the Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Blokx WAM; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

Publikováno v: JAMA network open [JAMA Netw Open] 2024 Aug 01; Vol. 7 (8), pp. e2426641. Date of Electronic Publication: 2024 Aug 01.